论文信息 - ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial - 字舞流文

ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial

M. Konopleva | K. Patel | D. Kipp | N. Daver | C. Dinardo | P. Marlton | A. Roberts | A. Wei | N. Pemmaraju | D. Curtis | C. Grove | S. Loghavi | I. Tiong | D. Westerman | A. Bajel | N. Anstee | D. Ross | P. Blombery | C. C. Chua | H. Iland | A. Ivey | R. Koldej | J. Reynolds | J. Collins | D. Ritchie | S. Loo | Amanda Souza